New, real-world data from a clinical study by Daymark Health, Blue Cross & Blue Shield of Rhode Island (BCBSRI), and Brown University Health, along with co-authors from the University of Pennsylvania ...

Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology, explains how AI is helping doctors, the challenges, ...

Cancer treatment is entering a new era in which doctors can target the genetic mutations driving a tumor rather than relying ...

Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based ...

Parabilis Medicines, Inc. stock: speculative Buy on peptide platform, early zolu efficacy, Orphan/Fast Track, and strong cash ...

Experts highlight KEYNOTE-C93, TroFuse-005, and antibody-drug conjugate data in platinum-resistant ovarian cancer at the ESMO Congress 2026.

Pfizer PFE will announce its third-quarter 2026 earnings on Nov. 3, and investors will be watching the performance of its oncology business closely, as the segment generates nearly 27% of the ...

The incorporation of Advanced Practice Providers (APPs) into the care of the oncology patient has been transformational to team-based care. APPs provide care and services that would otherwise require ...

McFarland, DO, and Ramy Sedhom, MD, discussed co-located psycho-oncology and palliative care, warm handoffs, and proactive distress screening. In this episode of Oncology On the Go, Daniel C.

AVEO Oncology, an LG Chem company, (AVEO) announced today that an abstract was accepted for presentation at the upcoming 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain ...

BridgeBio Oncology's total equity value of $226 million is lower than its liquid assets of $344.1 million as of June 30. See ...